ClinicalTrials.Veeva

Menu

Clinical Study for the BONGO Device in the Treatment of Obstructive Sleep Apnea (OSA)

I

InnoMed Healthscience

Status

Completed

Conditions

Obstructive Sleep Apnea

Treatments

Device: BONGO DEVICE

Study type

Interventional

Funder types

Industry

Identifiers

NCT02878590
INN-C003

Details and patient eligibility

About

Prospective, non-randomized, open label study

Full description

This study is a prospective, non-randomized, open label, single-center clinical study for the BONGO NASAL device for the treatment of obstructive sleep apnea. The study consists of two in laboratory polysomnographic studies and a one two week in home period.

Enrollment

23 patients

Sex

All

Ages

21+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • • Capacity and willingness to sign informed consent

    • ≥ 21 years of age
    • Diagnosis of mild to moderate OSA (AHI ≥ 5 and AHI ≤ 30) within 12 months of the screening visit with the 3% hypopnea criteria
    • Able to tolerate using the device during a day time trial/acclimation
    • Are currently using CPAP or have been prescribed CPAP and are considered CPAP non-adherent (as per either their CPAP data card and/or verbal confirmation of a diagnosis and unwillingness to use CPAP)

Exclusion criteria

  • • Nasal deformities

    • Severe nasal allergies
    • Rhinitis or moderate nasal congestion, acute upper respiratory (including nasal, sinus or middle ear) inflammation or infection, or perforation of the ear drum
    • Co-morbid sleep disorders
    • Currently on a hypnotic for insomnia (who have had insomnia for more than a month and take a hypnotic on a daily basis and/or transient insomnia being treated)
    • Uncontrolled or serious illness, including but not limited to: severe breathing disorders including hypercapnic respiratory failure, respiratory muscle weakness, bullous lung disease (as seen in some types of emphysema), bypassed upper airway, pneumothorax, pneumomediastinum, etc.; severe heart disease (including heart failure); or pathologically low blood pressure.
    • Full Face Mask user
    • Mouth breather
    • Pregnant (Female subjects of child bearing age will be asked if they are and/or planning on becoming pregnant during the study; acceptable methods of birth control include birth control pills and barrier method)

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

23 participants in 1 patient group

BONGO DEVICE
Experimental group
Description:
All participants that qualify will receive the intervention of the Bongo device
Treatment:
Device: BONGO DEVICE

Trial documents
1

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems